Although the occurrence of dilutional hyponatraemia and a myasthenic syndrome in association with malignant bronchial neoplasms has been recognized for some time (Anderson, Churchill-Davidson, and Richardson, 1953 ; Schwartz, Bennett, Curelop, and Bartter, 1957) , the finding of both these disorders in the same patient is of unusual interest. The characteristic clinical and electromyographic findings in patients with oat-cell carcinomas and myasthenia were given recently (Lambert, Eaton, and Rooke, 1956; Lambert and Rooke, 1965) , and the abnormality appears to be a defect of neuromuscular transmission in the rested muscle. There is good evidence that the syndrome of renal sodium loss and hyponatraemnia is due to inappropriate production of an antidiuretic substance by the tumour itself (Amatruda, Mulrow, Gallagher, and Sawyer, 1963; Bower, Mason, and Forsharn, 1964 Investigations.-The urine was normal, haemoglobin 13.9 g./ 100 ml., white-cell count normal, E.S.R. 7 mm. in one hour, plasma sodium 136 and potassium 4.8 mEq/l. Blood urea 24 mg./100 ml.; serum calcium 10.4 mg./100 ml. ; alkaline phosphatase 87 I.U./l. Serum proteins, electrophoresis, and empirical tests of liver function were normal. Resting urinary excretion of 1 7-ketogenic steroids was 13.9 mg./24 hours. The E.C.G. showed atrial fibrillation but no other abnormalities.
popliteal nerve motor-conduction velocity was 31 m./sec. (normal range 39-52 m./sec.). The sensory action potential recorded through surface electrodes over the right median nerve at the wrist in response to stimulation of the right index finger measured 15 ,AV (normal range 9-45 pV) with a latency of 3.9 msec. (normal range 2.5-4 msec.).
Edrophonium chloride and neostigmine had no effect on the ptosis or weakness. The bronchial neoplasm was inoperable, and he was treated with intravenous and oral cyclophosphamide, together with digoxin. Subsequently his condition deteriorated, with continuing loss of weight, and on readmission in September 1964 he was emaciated and ill, with hepatomegaly, generalized lymphadenopathy, and multiple subcutaneous metastases. Atrial fibrillation was still present ; blood-pressure 140/90 and no finger-clubbing In the nervous system the findings were unchanged except that the weakness at rest of proximal muscle groups in upper and lower limbs was more pronounced, although the increase in power after effort persisted. Electromyographic studies were repeated; they confirmed continued post-effort potentiation of the muscle action potentials.
Further investigations at this time showed no albumin, sugar, or casts in the urine. Haemoglobin was 12.8 g./100 ml., with a P.C.V. of 42%, a normal white count, and E.S.R. of 15 mm. in one hour. The plasma electrolytes were as follows: sodium 120, potassium 4.3, chloride 85, and bicarbonate 24 mEq/l. Serum magnesium 1.4 mg./100 ml. Blood urea 20 mg./100 ml. Serum calcium 10 mg./l00 ml. Serum proteins 6.8 g./100 ml. with normal electrophoresis. Alkaline phosphatase 200 I.U./l. Proteinbound iodine 5.8 ug./100 ml. The C.S.F. at this time had . sodium content of 140 mEq/l., potassium 2.6 mEq/l., chloride 101 mEq/l., and magnesium 1.04 mg./100 ml. Urinary electrolyte excretions: sodium 150 and potassium 40 mEq/24 hours. Urine osmolalities varied between 256 and 464 mOsm/kg. Urinary ketogenic steroid excretion was 13.2 mg./24 hours, plasma cortisol levels were 33.6 Mg./100 ml. at 9 a.m. and 24.4 /g./100 ml. at midnight in a single 24-hour period, and the urinary aldosterone excretion was 29 Mg./24 hours. The response to a standard oral metyrapone test was an increase in urinary ketogenic steroid excretion from 8 and 11 mg./24 hours in two control collections to 37 and 24 mg./ 24 hours on the first and second days of the test respectively Bioassays for vasopressin in both blood and urine were carried out while the patient was on an unrestricted fluid intake (Dr. Julius Lee, Charing Cross Hospital Medical School) , and these results are set out in the Table) . DISCUSSION Since Schwartz et al. (1957) described the cases of two patients with bronchogenic carcinoma and severe hyponatraemia, heavy renal sodium loss, and normal renal and adrenal function, and suggested that this was a dilutional hyponatraemia caused by an inappropriate secretion of antidiuretic hormone, further case reports have appeared, and this unusual metabolic complication of bronchial neoplasm is now well established (Ross, 1963) . Demonstration of large amounts of antidiuretic material in the urine of such a patient was provided by Thorn and Transbol (1963) , and the more recent finding of high concentrations of vasopressin in both blood and tumour in two further cases (Bower et (Landon, James, and Stoker, 1965) , although corticotrophin-like material has been isolated from tumour tissue in these patients (Meador, Liddle, Island, Nicholson, Lucas, Nuckton, and Luetscher, 1962) . The aldosterone excretion was towards the upper limit of normal and the results of injection of aldosterone suggested continued sensitivity of the renal tubules to administered aldosterone (see Chart). Lowering the dose of 9a-fluorohydrocortisone from 4 to 2 mg./day was associated with a slight fall in plasma sodium, but more striking was the diuresis which occurred on reinstituting the higher dosage after a few days. In spite of the suggestion here of an inhibitory effect on endogenous vasopressin production or action a high level of antidiuretic activity in the blood persisted.
In the cases of myasthenia showing post-effort potentiation of muscular activity studied by Lambert and Rooke (1965) , nearly all associated with bronchial neoplasms, no abnormalities in plasma electrolytes were reported. Treatment in our case was effective in restoring the electrolyte pattern towards normal but in no way influenced the Lambert-Eaton phenomenon, as recorded electromyographically, and it seems that the dilutional hyponatraemia and myasthenia were coincidental observations in this patient.
